Submit Content Become a member

Brisbane-based digital health company ResApp Health Limited (ASX:RAP) reports that  its SleepCheck direct-to-consumer smartphone application for the self-assessment of sleep apnoea, is now available in the App Store for iPhone in 36 countries.

SleepCheck uses the microphone on an iPhone to record and analyse an adult’s breathing and snoring patterns overnight. In a large clinical study, SleepCheck’s algorithms were shown to accurately assess a person’s risk of sleep apnoea when compared to a full sleep test. SleepCheck is a mobile medical application that is CE Marked in Europe and TGA approved for ARTG listing in Australia.

Sleep apnoea is a common sleep breathing disorder where the person repeatedly stops breathing or has periods of shallow breathing during sleep.

CEO and Managing Director, Tony Keating, said it has been estimated that 936 million people have sleep apnoea globally and up to 80% of people suffering from moderate or severe sleep apnoea are undiagnosed.

We are excited to expand the availability of SleepCheck to a total of 36 countries, covering a population of nearly a half a billion people,” Mr Keating said.

“SleepCheck is now translated into local languages in the European countries with the highest prevalence of sleep apnoea, including Germany, France and Spain, and we will continue to build out localised information for users.

“Undiagnosed sleep apnoea is a global issue, and SleepCheck offers consumers the only clinical grade, regulatory-approved screening app able to accurately assess their risk of sleep apnoea.”

SleepCheck version 1.3 is now available in English, German, French, Portuguese, Spanish and Italian and is available to purchase in the App Store for iPhone throughout Europe (including the United Kingdom), Australia, New Zealand, Hong Kong and Singapore.

In addition to translations, SleepCheck v1.3 now saves the user’s age, gender and neck size for easier repeat testing, and provides additional educational material on sleep apnoea, its symptoms and risks, and treatment options.

https://www.resapphealth.com.au/

Rate article from Staff Writers: